| ［1］ Avery ME， Tooley WIJ，Keller JB，et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers［J］. Pediatrics，1987，79:26-30. ［2］ Colin J， Morley PG，Davis LW，et al. Nasal CPAP or intubation at birth for very preterm infants［J］. N Engl J Med，2008，358:700-708. ［3］ Bhandari V， Gavino RG， Nedrelow JH， et al. A randomized control trial of synchronized nasal intermittent positive pressure ventilation in RDS［J］. J Perinatol，2007，27:697-703. ［4］ Miller J， Carlo W. Safety and effectiveness of permissive hypercapnia in the preterm infant［J］. Curr Opin Pediatr，2007，191:142-144. ［5］ Halliday HL.Guideline on neonatal steroids［J］. Prenat Neonat Med， 2001，6:371-373. ［6］ Committee on fetus and newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants［J］. Pediatrics， 2002，109:330-338. ［7］ Committee on fetus and newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants［J］. Pediatrics， 2010，126:800-808. ［8］ Allen J， Zwerdling R， Ehrenkranz R. Statement on the care the child with chronic lung disease of infancy and childhood［J］. Am J Respir Crit Care Med，2003，168:356-396. ［9］ Askie LM， Ballard RA， Cutter GR， et al. Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials［J］. Pediatrics，2011，128:729-739. ［10］ Donohue PK，Gilmore MM，Cristofale E， et al. Inhaled nitric oxide in preterm infants: A systemic review［J］. Pediatrics，2011，127:e414-422. ［11］ Schreiber MD， Gin-Mestan K， Marks JD， et al. Inhaled nitric oxide in preterm infants with respiratory distress syndrome［J］. N Eng J Med，2003， 349:2099-2107. ［12］ Schmidt B， Robert RS， David P， et al. Caffeine therapy for apnea of prematurity［J］. N Eng J Med，2006，354(20）:2112-2121. |
